Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine

US9750754B2 · kind B2 · utility

Assignee

• GLENMARK SPECIALTY S.A. · CH

Inventors

• Ulhas R. Dhuppad · Jamkhed, IN
• Ashok Katkurwar · Ashti, IN
• Yashwant Gupta · Jamkhed, IN
• Rajesh Ankam · Jamkhed, IN
• Chandrakant Dhatrak · Jamkhed, IN

Key dates

• Filing date: Jun 15, 2016
• Grant date: Sep 5, 2017
• Expiry date: Jun 15, 2036

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/38
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.